Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 3, 2008, Pages 888-894

  Pearce, Elizabeth N ^a   Wilson, Peter W F ^c   Yang, Qiong ^b   Vasan, Ramachandran S ^d   Braverman, Lewis E ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHYROIDISM; LIPID ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; THYROID FUNCTION; THYROIDECTOMY;

EID: 40849142090     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1987     Document Type: Article

References (42)

1. 4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499
2. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P 1985 The aging thyroid: thyroid deficiency in the Framingham Study. Arch Int Med 145:1386-1388
3. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado Thyroid Disease Prevalence Study. Arch Int Med 160:526-534
4. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA 1998 Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary disease. Arterioscler Thromb Vasc Biol 18:1046-1053
5. Mackey RH, Kuller LH, Sutton-Tyrell K, Evans RW, Holubkov R, Matthews KA 2002 Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the Healthy Women Study. Am J Cardiol 90:71i-76i
6. Kuller L, Arnold A, Tracy R, Otvos J, Burke G, Psaty B, Siscovick D, Freedman DS, Kronmal R 2002 Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 22:1175-1180
7. Rosenson RS, Otvos JD, Freedman DS 2002 Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-1) trial. Am J Cardiol 90:89-94
8. Dawber TR, Meadors GF, Moore Jr FE 1951 Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 41:279-281
9. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP 1979 An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 110:281-290
10. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW, Schaefer EJ 2004 Sex and age differences in lipoprotein subclass measured by nuclear magnetic resonance spectroscopy: The Framingham Study. Clin Chem 50:1189-1200
11. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 18:499-502
12. Duntas LH 2002 Thyroid disease and lipids. Thyroid 12:287-293
13. Pearce EN 2004 Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr Cardiol Rep 6:451-456
14. Agdeppa D, Macaron C, Mallik T, Schnuda ND 1979 Plasma high density lipoprotein cholesterol in thyroid disease. J Clin Endocrinol Metab 49:726-729
15. Aviram M, Luboshitzky R, Brook JG 1982 Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. Clin Biochem 15:62-66
16. Lithell H, Boberg J, Hellsing K, Ljunghall S, Lundqvist G, Vessby B, Wide L 1981 Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy. Eur J Clin Invest 11:3-10
17. Tan KCB, Shiu SWM, Kung AWC 1998 Plasma cholesteryl ester transfer protein activity in hyper- and hypothyroidism. J Clin Endocrinol Metab 83:140-143
18. Lam KS, Chan MK, Yeung RT 1986 High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction: effects of treatment. Q J Med 59:513-521
19. Johanssen L, Rudling M, Scanlan TS, Lundasen T, Webb P, Baxter J, Angelin B, Parini P 2005 Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc Natl Acad Sci USA 102:1297-1302
20. Biondi B, Palmieri EA, Lombardi G, Fazio S 2002 Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904-914
21. Nyirenda MJ, Clark DN, Finlayson AR, Read J, Elders A, Bain M, Fox KA, Toft AD 2005 Thyroid disease and increased cardiovascular risk. Thyroid 15:718-724
22. Walsh JP, Bremner AP, Bulsara MK 2005 Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467-2472
23. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW 2006 Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033-1041
24. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Evans JG, Rodgers H, Tunbridge F, Young ET 1996 The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6:155-160
25. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfeld S, Harris TB, Bauer DC 2005 Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460-2466
26. Parle J, Maisonneuve P, Sheppard M, Betteridge J, Boyle P 2001 A single low thyrotropin (TSH) concentration predicts increased all-cause mortality in older persons in the community: a 10-year cohort study. Lancet 358:861-865
27. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashizawa K, Yokoyama N, Maeda R, Nagataki S, Eguchi K 2004 Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 89:3365-3370
28. Gussekloo J, van Exel E, de Craen AJM, Meinders AE, Frolich M, Westendorp RGJ 2004 Thyroid status, disability and cognitive function, and survival in old age. JAMA 292:2591-2599
29. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC 2006 Subclinical hypothyroidism and the risk of coronary heart diseased: a meta-analysis. Am J Med 119:541-551
30. Völzke H, Schwahn C, Wallachofski H, Dorr M 2007 The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? J Clin Endocrinol Metab 92:2421-2429
31. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R, Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol, in press
32. Rizzo M, Berneis K 2006 Low-density lipoprotein size and cardiovascular risk assessment. QJM 11:1-14
33. Carmena R, Duriez P, Fruchart JC 2004 Atherogenic lipoprotein particles in atherosclerosis. Circulation 109:2-7
34. Sacks FM, Campos H 2003 Low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab 88:4525-4532
35. Roscini AR, Lupattelli G, Siepi D, Pagliaricci S, Pirro M, Mannarino E 1999 Low-density lipoprotein size in primary hypothyroidism: effects of hormone replacement therapy. Ann Nutr Metab 43:374-379
36. Ozcan O, Cakir E, Yaman H, Akgul EO, Erturk K, Beyhan Z, Bilgi C, Erbil MK 2005 The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Clin Endocrinol 63:203-206
37. Sundaram V, Hanna HF, Koneru L, Newman HAI, Falko JM 1997 Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab 82:3241-3244
38. Diekman T, Diemacker PN, Kastelein JJP, Stalenhoeff AFH, Wiersinga WM 1998 Increased oxidizability of low-density lipoproteins in hypothyroidism. J Clin Endocrinol Metab 83:1752-1755
39. Franklyn JA 2000 Metabolic changes in hypothyroidism. In: Braverman LE, Utiger RD, eds. The Thyroid. 8th ed. Philadelphia: Lippincott Williams, Wilkins; 833-836
40. Otvos J, Jeyarajah E, Bennett D 1996 A spectroscopic approach to lipoprotein subclass analysis. J Clin Ligand Assay 19:184-189
41. Tan KCB, Shiu SWM, Kung AWC 1998 Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein. J Clin Endocrinol Metab 83:2921-2924
42. Pazos F, Alvarez JJ, Rubies-Prat J, Varela C, Lasuncion MA 1995 Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. J Clin Endocrinol Metab 80:562-566